Devyser Diagnostics AB (publ) (STO:DVYSR)
Sweden · Delayed Price · Currency is SEK 62.20
-0.10 (-0.16%)
Jul 24, 2026, 5:29 PM CET
Devyser Diagnostics AB Market Cap
Devyser Diagnostics AB has a market cap or net worth of 1.05 billion as of July 24, 2026. Its market cap has decreased by -56.81% in one year.
Market Cap
1.05B
Enterprise Value
1.02B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
62.20
ChartMarket Cap Chart
Since December 10, 2021, Devyser Diagnostics AB's market cap has decreased from 1.35B to 1.05B, a decrease of -22.28%. That is a compound annual growth rate of -5.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 1.05B | -44.76% |
| Dec 30, 2025 | 1.90B | -2.79% |
| Dec 30, 2024 | 1.96B | 52.85% |
| Dec 29, 2023 | 1.28B | 11.06% |
| Dec 30, 2022 | 1.15B | -14.36% |
| Dec 30, 2021 | 1.35B | -0.45% |
| Dec 10, 2021 | 1.35B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CellaVision AB | 3.34B |
| C-Rad AB | 1.25B |
| Paxman AB | 1.09B |
| BICO Group AB | 944.29M |
| Sedana Medical AB | 861.25M |
| Senzime AB | 565.97M |
| Bactiguard Holding AB | 555.45M |
| OssDsign AB | 440.84M |